Roles
- Professor of Clinical Neurology & Neurosurgery
- Chief, Interventional Neurology
- Co-Director, Endovascular Neurosurgery
- Director Neurological Stem Cell Platform, Interdisciplinary Stem Cell Institute
-
Biography
Dr. Dileep R. Yavagal is the Chief of Endovascular Division, Director of Interventional Neurology and Co-Director of Neuroendovascular Surgery and Clinical Professor of Neurology and Neurosurgery at the University of Miami & Jackson Memorial Hospitals. He is also the Director of NeuroStem Cell Division at the Interdisciplinary Stem Cell Institute. Dr. Yavagal is an international thought leader in endovascular therapy for ischemic and hemorrhagic stroke. -
Education & Training
Education
Post Graduate Training
-
Research Interests
Dr. Yavagal is a leader in both pre-clinical and clinical stroke as well as other neuroendovascular research. The translational approach of his work has allowed him to run a successful large and small animal research lab as well as initiate and collaborate with stake holders for cutting edge stroke clinical trials. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Miller School of Medicine Neurologist Calls for Global Action on Stroke Treatment Access
Stem Cell Delivery Approach Shows Promise for Stroke Recovery
Dr. Dileep Yavagal Receives Lifetime Achievement Award at AAN 2026
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 9 clinical trials.
-
The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Closed
-
Study Intended Patient Population:Acute ischemic stroke (AIS) patients with an intracranial vessel occlusion (IVO) in the anterior circulation and extracranial proximal carotid occlusion or severe stenosis; within 16 hours of symptom onset. Primary Aim:- To establish the efficacy of intra-arterial (IA)mechanical thrombectomy (MT)with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circulation and have a proximal carotid occlusive disease (occlusion or severe stenosis) within 16 hours of symptom onset. Secondary Aims1) To determine the rate of acute carotid stent thrombosis in patients acutely stented2) To determine best periprocedural antiplatelet regimen (oral antiplatlet or IV Antiplatelet (e.g., Cangrelor)).
- Principal Investigator: Dileep Yavagal
- Study Phase: TBD
- Enrollment Status: Open
-
Embotrap eXtraction & Clot EvaLuation & Lesion Evaluation for NeuroThrombectomy
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Closed
-
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Open
-
The objective of this study is to assess the primary safety and effectiveness ofmechanical thrombectomy (MT) using the ANA funnel catheter in its intended use asa device to facilitate the insertion and deployment of other devices (i.e., stentretrievers and intravascular catheters) and to allow flow restriction during MTprocedures performed in subjects experiencing acute ischemic stroke (AIS)secondary to large vessel occlusion (LVO) and treated within 24 hours of symptom ONSET.
- Principal Investigator: Dileep Yavagal
- Study Phase: TBD
- Enrollment Status: Open
-
N/A
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Not Accepting
-
Patient SF has been under the care of Dr. David H. Harter, MD, Associate Professor of Neurosurgery, at NYU Langone Medical Center since his initial presentation in July of 2017. SF underwent resection of a high-grade glioma, and underwent multimodal therapy chemo- and radiation therapy. SF subsequently developed a remote recurrence along the septum pellucidum, with hydrocephalus. He underwent shunt placement and returned to Florida. There, he had a shunt malfunction, likely due to tumor infiltration. He had a significant deterioration, and has remained unresponsive since. His recent imaging is difficult to interpret. He has no evidence of progressive tumor growth or leptomeningeal spread.
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Open
-
A single-arm, open-label, ONE-center (JMH and UM) EXPANDED ACCESS experimental treatment involving the intravenous infusion of allogeneic human mesenchymal stem cells in subjects following an acute ischemic stroke.
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Closed
-
A Prospective, Randomized, Controlled, Interventional Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPoint Reperfusion System for Aspiration Embolectomy in Acute Ischemic Stroke Patients
- Principal Investigator: Dileep Yavagal
- Study Phase: N/A
- Enrollment Status: Closed